Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates.
Snoeck E, Piotrovskij V, Jacqmin P, Van Peer A, Danhof M, Ver Donck K, Woestenborghs R, Van Belle H, Van Bortel L, Van Gool R, Dupont AG, Heykants J.
Snoeck E, et al. Among authors: van gool r, van belle h, van bortel l, van peer a.
Br J Clin Pharmacol. 1997 Jun;43(6):603-12. doi: 10.1046/j.1365-2125.1997.00593.x.
Br J Clin Pharmacol. 1997.
PMID: 9205820
Free PMC article.
Clinical Trial.